• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes: C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T. O'Brien J Urol 2016; 195: 1697-1703.

作者信息

Shenoy Sunil P, Marla Prashanth K, Sharma Pritam, Batchu Chandu Krishna, Reddy Vijayanand R, Pai Vivek Mangalore

机构信息

Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India.

Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India.

出版信息

J Urol. 2017 Apr;197(4):1173-1174. doi: 10.1016/j.juro.2016.12.007. Epub 2016 Dec 28.

DOI:10.1016/j.juro.2016.12.007
PMID:28039743
Abstract
摘要

相似文献

1
Re: Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes: C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T. O'Brien J Urol 2016; 195: 1697-1703.回复：卡介苗/丝裂霉素C电动药物灌注序贯疗法作为高危非肌层浸润性膀胱癌的标准膀胱内治疗方案：2年结果：C. 甘、S. 阿梅里、K. 查特顿、M. S. 汗、K. 托马斯和T. 奥布赖恩 《泌尿外科杂志》2016年；第195卷：第1697 - 1703页
J Urol. 2017 Apr;197(4):1173-1174. doi: 10.1016/j.juro.2016.12.007. Epub 2016 Dec 28.
2
Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.序贯卡介苗/电动力药物注射丝裂霉素 C 作为高危非肌层浸润性膀胱癌的标准膀胱内治疗方案：2 年结果。
J Urol. 2016 Jun;195(6):1697-703. doi: 10.1016/j.juro.2016.01.103. Epub 2016 Feb 2.
3
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌：系统评价和荟萃分析。
J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.
4
Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.回复：汤姆·J.H.·阿伦兹、奥费·纳蒂夫、马西莫·马费齐尼等。一项比较膀胱内热化疗联合丝裂霉素C与卡介苗辅助治疗中高危非肌层浸润性膀胱癌患者的随机对照试验结果。《欧洲泌尿外科杂志》2016年；69卷：1046 - 52页。
Eur Urol. 2017 Jan;71(1):e29-e30. doi: 10.1016/j.eururo.2016.06.042. Epub 2016 Jul 11.
5
Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.回复：汤姆·J.H.·阿伦兹、奥费·纳蒂夫、马西莫·马费齐尼等。一项随机对照试验的结果：比较膀胱内热化疗联合丝裂霉素C与卡介苗对中高危非肌层浸润性膀胱癌患者的辅助治疗。《欧洲泌尿外科杂志》2016年；69卷：1046 - 52页
Eur Urol. 2019 Feb;75(2):e25. doi: 10.1016/j.eururo.2018.08.046. Epub 2018 Sep 17.
6
Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non-muscle-invasive bladder cancer.当代成本效益分析：比较序贯卡介苗和电动丝裂霉素与单独使用卡介苗治疗高危非肌层浸润性膀胱癌患者的效果
Cancer. 2014 Aug 15;120(16):2424-31. doi: 10.1002/cncr.28731. Epub 2014 Apr 18.
7
Re: Willem Oosterlinck, Ziya Kirkali,Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTCGenito-urinary Group Randomized Phase 2 Trial (30993). Eur Urol 2011;59:438-46.回复：威廉·奥斯特林克、齐亚·基尔卡利、理查德·西尔维斯特等。膀胱原位癌患者序贯膀胱内丝裂霉素C与卡介苗化疗免疫疗法及单纯卡介苗化疗免疫疗法：欧洲癌症研究与治疗组织泌尿生殖组随机2期试验（30993）结果。《欧洲泌尿外科杂志》2011年；59卷：438 - 46页
Eur Urol. 2011 Jul;60(1):e1; author reply e2-3. doi: 10.1016/j.eururo.2011.03.050. Epub 2011 Apr 5.
8
Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.回复斯拉沃米尔·波莱塔耶夫、彼得·拉齐谢夫斯基、胡安·帕洛致编辑的信：关于汤姆·J.H. 阿伦兹、奥费·纳蒂夫、马西莫·马费齐尼等人的“一项比较膀胱内热化疗联合丝裂霉素C与卡介苗辅助治疗中高危非肌层浸润性膀胱癌患者的随机对照试验结果”。《欧洲泌尿外科杂志》2016年；69卷：1046 - 52页
Eur Urol. 2017 Jan;71(1):e31-e32. doi: 10.1016/j.eururo.2016.06.043. Epub 2016 Jul 15.
9
Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.回复哈什特·加尔格、布鲁萨巴胡努·纳亚克和普拉布乔特·辛格致编辑的信：关于汤姆·J.H. 阿伦兹、奥费·纳蒂夫、马西莫·马费齐尼等人。一项随机对照试验的结果，比较膀胱内热化疗联合丝裂霉素C与卡介苗用于中高危非肌层浸润性膀胱癌患者辅助治疗的疗效。《欧洲泌尿外科杂志》2016年；69:1046 - 52。
Eur Urol. 2019 Feb;75(2):e26. doi: 10.1016/j.eururo.2018.08.045. Epub 2018 Sep 26.
10
Re: Sequential Intravesical Mitomycin plus Bacillus Calmette-Guérin for Non-Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial.回复：丝裂霉素与卡介苗序贯膀胱灌注治疗非肌层浸润性尿路上皮膀胱癌：转化研究与I期临床试验
J Urol. 2016 Sep;196(3):688-9. doi: 10.1016/j.juro.2016.06.035. Epub 2016 Jun 15.